Evidence map›Paper›PMID 41934286›Full record

ArticleInternational journal of stroke : official journal of the International Stroke Society2026

The importance of advocacy in advancing stroke care: The global stroke action coalition.

Michelle LA Nelson, Maria Grupper, H B van der Worp, Nicoletta Brunelli, Narayanaswamy Venketasubramanian, Fawaz Al-Mufti, Kaiz Asif, Ruth Asperen, Angelique Balguid, Sarah Belson and 13 more

Abstract read
In one paragraph

Article in International journal of stroke : official journal of the International Stroke Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Michelle LA NelsonBruyere Health Research Institute, Bruyere Health, Ottawa, ON, Canada.ORCID 0000-0003-2002-0298
Maria GrupperWorld Stroke Organization, Geneva, Switzerland.
H B van der WorpDepartment of Neurology and Neurosurgery, University Medical Center, Utrecht, The Netherlands.
Nicoletta BrunelliStroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Stroke Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.ORCID 0000-0002-8590-9015
Narayanaswamy VenketasubramanianRaffles Neuroscience Centre, Singapore.
Fawaz Al-MuftiSVIN: Mission Thrombectomy, Washington, DC, USA.
Kaiz AsifSVIN: Mission Thrombectomy, Washington, DC, USA.
Ruth AsperenPhilips, Washington, DC, USA.
Angelique BalguidPhilips, Washington, DC, USA.
Sarah BelsonWorld Stroke Organization, Geneva, Switzerland.
Deidre A De SilvaSingapore General Hospital campus, National Neuroscience Institute, Singapore.ORCID 0000-0002-7123-2381
Belen Velazquez GarciaBoehringer Ingelheim Corporate Center, Ingelheim am Rhein, Germany.
Signe HaughtonMedtronic, Minneapolis, MN, USA.
Yong JiangBeijing Tiantan Hospital, Capital Medical University, Beijing, China.
Amy MasonBayer, Berlin, Germany.
Sheila MartinsWorld Stroke Organization, Geneva, Switzerland.
Pamela NaidooThe Heart and Stroke Foundation, Cape Town, South Africa.ORCID 0000-0003-0326-5322
Jeyaraj PandianWorld Stroke Organization, Geneva, Switzerland.ORCID 0000-0003-0028-1968
Michele Schaub JacksonEuropean Stroke Organisation, Basel, Switzerland.
Katherine SetumMedtronic, Minneapolis, MN, USA.
Christina SperlingMarch of Dimes Canada, Toronto, ON, Canada.
Yongjun WangBeijing Tiantan Hospital, Capital Medical University, Beijing, China.
Bo NorrvingDepartment of Clinical Sciences, Neurology, Lund University, Lund, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stroke represents one of the most significant global health challenges of the 21st century, with 11.9 million people experiencing stroke annually and a disproportionate burden falling on low- and middle-income countries, where 87% of stroke deaths and 89% of disability occur. Despite stroke being highly preventable-with 84% of the burden attributable to modifiable risk factors-and the availability of treatments that have proven to reduce the rate of death or disability, including stroke units, thrombolysis, and thrombectomy, these interventions remain inaccessible to most of the world's population. Advocacy-systematic efforts to influence policy, practice, and resource allocation through evidence-based engagement with decision-makers-has achieved notable successes such as establishing stroke units globally. However, individual advocacy efforts face structural limitations in addressing global stroke challenges. The Global Stroke Action Coalition (GSAC) was formed in 2024 as a coordinated, multi-sectoral initiative convened by the World Stroke Organization, uniting scientific, civil societies, and industry partners to transcend these limitations. The Coalition leverages established infrastructure and expertise to create a unified advocacy force capable of commanding attention from global health leaders. Centered around five strategic priorities-integrating stroke into national non-communicable disease (NCD) strategies, developing National Stroke Action Plans, securing funding commitments, implementing monitoring systems, and including survivors in policy development-the Coalition successfully utilized the 2025 UN High-Level Meeting on Non-Communicable Diseases to further elevate the position of stroke on the global agenda. Key achievements include securing ministerial commitments from 10 countries and launching the "Every Minute Counts" campaign. The Coalition's coordinated approach demonstrates that systematic, evidence-based advocacy can transform stroke care delivery globally, providing a framework for sustained collaboration across sectors and regions essential for meeting Sustainable Development Goal targets and reducing the devastating burden of stroke worldwide.

Indexed as

Patient AdvocacyStrokeGlobal HealthHumansAdvocacyeconomicsnon-communicable diseasespolicypreventionstroketreatment

Identifiers

PMID41934286
PMCPMC13197608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.